chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Dizziness; fatigue; Headache; Swelling at injection site; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DIZZINESS (Dizziness), FATIGUE (fatigue), HEADACHE (Headache) and INJECTION SITE SWELLING (Swelling at injection site) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced CHILLS (Chills), DIZZINESS (Dizziness), FATIGUE (fatigue), HEADACHE (Headache), INJECTION SITE SWELLING (Swelling at injection site), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, CHILLS (Chills), DIZZINESS (Dizziness), FATIGUE (fatigue), HEADACHE (Headache), INJECTION SITE SWELLING (Swelling at injection site), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Felt small bumps at first, by next morning they were splotches and red, day after that they had grown
CHILLS; BODY ACHES; HEADACHES; MIGRAINES; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced headaches. On 06-MAR-2021, the subject experienced migraines. On 07-MAR-2021, the subject experienced chills. On 07-MAR-2021, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and body aches on 07-MAR-2021, and had not recovered from headaches, and migraines. This report was non-serious.
Left arm pain day after injection followed by left arm pit swelling of gland with pain, low grade fever,headache.
pt recvd vax 14OCT92 & 29OCT92 pt  exp numbness & tingling of lip; 1NOV92 exp severe lt ear pain; sx progressed to include weakness of eyes & mouth; 3NOV92 following day presented to MD & was dx w/Bell's palsy; 14DEC92 pt had recovered;
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. Since 04-NOV-2015, on unspecified dates, the patients were vaccinated with unspecified doses of improperly stored MMR II (lot # K024825, expiry date 02-DEC-2016; lot # L012479, expiry date 10-APR-2017) (strength, dose and route were unspecified). No adverse effects had been reported. This is one of several reports received from the same source. Additional information has been requested.
30 minutes of post injection, Tingling in fingers, Fluttery heart, Weak, Feverish, Eyes, Fingers swelling, Nausea, Achy joints.
Severe headache and fatigue developed the night of vaccination.  The following day developed fever of 100.44, chills, full body aches, and severe headache.  Continued until morning of 2/1/21.
The patient felt fine after the vaccine at 12 noon on 03/05,  she woke up on 03/06 at about 6:00 a.m. and noted numbness  around her mouth and jaw,  that felt similar to the numbness one experiences after going to the dentist.  However, the patient has not gone to the dentist at all recently.  This lasted most of the day and then mostly self-resolved.  She still has a little bit of numbness around her lips.   She never had any sensation of her throat closing up.  She did not need to use an EpiPen.  She is a bit concerned about getting her 2nd vaccine and if this will occur again.
The next day the arm was numb. Following has been a leg numb for past 3 months. Headaches. Tingling in arms and legs. Shooting pain in limbs. Problems with vision. She had MRI. Echo test, a lot of blood work, many trips to ER.
30 May 2021 I was diagnosed as an otherwise healthy male with pulmonary embolism in the lower right lung. No predispositions to blood clots.
Large knot on her injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Large knot on her injection site arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE MASS (Large knot on her injection site arm). At the time of the report, VACCINATION SITE MASS (Large knot on her injection site arm) outcome was unknown.            No concomitant medications were provided. Treatment information was not provided.   This case was linked to MOD-2021-300510 (Patient Link).
Developed redness/tenderness and swelling 24 hours after vaccination which patient reports caused severe pain in left shoulder requiring visit to ED 10/19/02. Given Ancef, Keflex for cellulitis. Now on prednisone.
Instead of drawing 0.5 ml dosage from the vial she drew 0.4 ml each time; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Instead of drawing 0.5 ml dosage from the vial she drew 0.4 ml each time) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .4 milliliter. On an unknown date, the patient experienced UNDERDOSE (Instead of drawing 0.5 ml dosage from the vial she drew 0.4 ml each time). At the time of the report, UNDERDOSE (Instead of drawing 0.5 ml dosage from the vial she drew 0.4 ml each time) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided  Treatment medication was not provided
Patient was given the Pfizer-BioNTech vaccines for his Booster shot but patient wanted the Moderna vaccines to complete his 3 series. At the time of call on 10/07/21, patient does not appear to show any adverse effects.
Felt "loopy" 15 min. after receiving vaccine, but states he did not report it to vaccinator. 10/8/21 Felt tongue swelling at the end of the day 10/9/21 Called Primary care physician because tongue still felt swollen, and tongue had muscle spasms that could be both felt and visualized. PCP prescribed over the counter Advil x 3 days (patient experiences sudden weakness with Benadryl). Patient reported to emergency department at 1430 after he felt whole body weakness. ED administered IV fluids.  10/10/21 Tongue swelling gone 10/11/21 Tongue tingling gone
My period came 9 days early. (My period is always extremely regular at every 27-28 days.) I have never taken birth control. Period volume and cramps did not seem to be much different.
I woke up and had a very severe pain in my chest & then it started making my lungs hard to breath then I started having indigestion & it was a pain like no other, so I called 911 and was taken to the hospital.
got infected with Covid-19 virus 2 weeks ago; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sponsored Program. A female patient of an unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine, solution for injection, Lot number unknown), via an unspecified route of administration on 16Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 24Mar2021, patient got infected with COVID-19 virus. The patient wants to reschedule the second dose as a result of the event. The outcome of the event COVID-19 was unknown. The patient underwent lab test which included SARS-CoV-2 Test: Positive on 24Mar2021.
Myocarditis; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (Myocarditis) in a 19-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 015H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Nov-2022, the patient experienced MYOCARDITIS (Myocarditis) (seriousness criteria hospitalization and medically significant). At the time of the report, MYOCARDITIS (Myocarditis) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2022, Brain natriuretic peptide: Mildly elevated. In November 2022, Fibrin D dimer: Mildly elevated. In November 2022, Troponin I: 7.04.         No concomitant medications were reported.  It was reported that symptoms started on 24-Nov-2022 with chest pain. Escalated to orthopnea, diaphoresis and tachypnea with worsening chest pain by 25-Nov-2022.  No treatment medications were reported.  Company comment This spontaneous case concerns 19-year-old patient of an unknown gender with no medical history reported, who experienced the expected, serious (medically significant and hospitalization) AESI of myocarditis, which occurred six days after a dose of mRNA-1273.222 (BA.4/BA.5) vaccine (Spikevax Bivalent Original/Omicron BA.4-5). It was reported that the patient started with symptoms of chest pain, then added orthopnea, diaphoresis, tachypnea with worsening chest pain. The patient went to the emergency department, and was admitted with Troponin I of 7.04, mildly elevated BNP and D-Dimer. The patient was diagnosed with myocarditis. No further clinical information was available for review. The benefit-risk relationship of mRNA-1273.222 (BA.4/BA.5) Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns 19-year-old patient of an unknown gender with no medical history reported, who experienced the expected, serious (medically significant and hospitalization) AESI of myocarditis, which occurred six days after a dose of mRNA-1273.222 (BA.4/BA.5) vaccine (Spikevax Bivalent Original/Omicron BA.4-5). It was reported that the patient started with symptoms of chest pain, then added orthopnea, diaphoresis, tachypnea with worsening chest pain. The patient went to the emergency department, and was admitted with Troponin I of 7.04, mildly elevated BNP and D-Dimer. The patient was diagnosed with myocarditis. No further clinical information was available for review. The benefit-risk relationship of mRNA-1273.222 (BA.4/BA.5) Vaccine is not affected by this report.
Patient recieved Varicella on 08/16/2007 right leg SQ, ON 08/27/2007 Patient called office 08/27/2007 c/o redness and swelling at sight
Pt recvd vax on 14NOV92 following vax approx 24 hrs pt devel a prickly heat type rash on inner arms & palms;
arm hurt for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt for 24 hours) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included LISINOPRIL for Blood pressure high, DILTIAZEM and PANTOPRAZOLE SODIUM for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt for 24 hours). At the time of the report, PAIN IN EXTREMITY (arm hurt for 24 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.   This case was linked to MOD-2021-054585 (Patient Link).
5 minutes after shot patient complained of throat tightening but not distressed; sat patient down administered 10ml BENADRYL and prepared to give EPIPEN pending worsening of symptoms. 10 minutes later sat with patient and companion and was told "all ok" told to wait 10 minutes and then left with no symptoms. Called next A.M. to confirm that all was well and it was.
Complaint is subjective: Patient and parent called to inform facility that once patient made it home she became sick. She work up around 4AM the next morning and walked to the bathroom she became dizzy she grabbed onto the sink and started to see dark spots and she woke up later on the floor. She stated she woke up on her own. She stated she don't recall how long she was out. I told parent and patient to report to the ER for observation even if she feels better.
Received the dose in Jan 2023 in the same arm as prior 4 Covid shots and within the week ,?5-6 days, I started noticing ringing in my Right ear. It is most noticeable in the PM hours. I never had any ringing in my ears prior to Jan 2023.
constantly coughing; fatigue; low grade fever; felt nauseous; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (constantly coughing), FATIGUE (fatigue), PYREXIA (low grade fever) and NAUSEA (felt nauseous) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Shingles and Cough. Concomitant products included BENZONATATE for Cough, NIFEDIPINE for Hypertension, GABAPENTIN (GABAPENTIN "PCD") for Shingles, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced COUGH (constantly coughing), FATIGUE (fatigue), PYREXIA (low grade fever) and NAUSEA (felt nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN (CORICIDIN HBP CHEST CONGESTION & COUGH) for Cough, at an unspecified dose and frequency. At the time of the report, COUGH (constantly coughing), FATIGUE (fatigue), PYREXIA (low grade fever) and NAUSEA (felt nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included multivitamins for immunity and aspirin for blood thinner.
Patient was receiving vaccine from pharmacist, as pharmacist was inserting needle, needle went through the patients skin and punctured the pharmacist. Exchange of blood occurred, pharmacist is currently receiving blood tests and PEP and patient is currently being contacted to start the treatment process.
Arm is quite painful.. Can hardly lift it.  Can't sleep on it.  About 1 AM this morning I woke up with terrible chills. Could not go back to sleep.     Finally got out of bed @2:30 am.  I feel very tired, week and ache all over my body much like the flu.  Also TERRIBLE Headache.   A low grade of fever too.
One week after the first dose of the vaccine I developed a rash which started underneath my arm. It looked like Eczema. My Eczema medicine seemed to work but it came back. It started to appear under the other arm as well. I sometimes get a similar rash in the spring but there is no blisters. One month later I started to get blisters with the rash. It covers the entire underarm area of both arms. It was worse on the left side of my body. I went to the doctor and prescribed some antibiotics which helped at first in May, The blisters would not burst and they spread out and changed color. After the antibiotics were gone the rash returned. The blistered were very painful and testing revealed that they are not bacterial. Currently after four months I am using a cream and an ointment and they have helped. The rash had improved a little before I got my second dose but then it returned with the blisters.
"4 huge whelps" raised, red, warm, itching area at injection site. Pt took OTC children's BENADRYL, visited Dr. advised to take CLARITIN. Reaction began at 1 am 8/21/10 and continued to 8/23/10. At 8/23/10 pt stated MD told her that it was an allergic reaction and to report to Health Dept.
Hives broke out on arm from injection site to wrist on the arm where seasonal influenza vaccine was given.  Child has recieved both seasonal flu vaccine and H1N1 flu vaccine in the past.  No history of prior egg allergy or chicken allergy or other known allergies. Mother recognized allergic reaction and administered appropriate dose of Benadryl.  She contacted her child's PCP and informed; not seen but they suggested it was due to seasonal flu vaccine.
The next day, I started to feel really weird. I had no energy and my head felt really strange. About a week and a half later, around 5am, the left side of my body started going numb. My wife took me to the ER. My BP was super high. About 6 hours later, the numbness started to go away. They performed various tests, but couldn't find anything wrong. They think I had a TIA, which is a blood clot that resolves itself. For the following month or so, I was just extremely tired and felt really crappy.
Information has been received from a nurse practitioner concerning a 12-13 year old female who on an unspecified date was vaccinated with a dose of GARDASIL.  Subsequently the patient developed an indentation at the injection site growing from quarter size to a half dollar size.  Unspecified medical attention was sought.  At the time of the report, the patient was recovering.  Additional information has been requested.
Information has been received from a registered nurse concerning 3 patients who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (lot#665708/0651Z). On the next day, the patients developed edema and cellulitis. At the time of this report, the patients' outcomes were not reported. Edema and cellulitis were considered to be disabling by the reporter. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports from the same source. Additional information has been requested.
Rashes on face. 3 on head. 10 on stomach. 5 on each leg. not developed to blister
Couldn't move my body; Body aches; Nauseous; Headache; Chills - literally body shaking; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Couldn't move my body), PAIN (Body aches), NAUSEA (Nauseous), HEADACHE (Headache) and CHILLS (Chills - literally body shaking) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from 30-Dec-2020 to January 2021 and Breast cancer in 2018. Previously administered products included for an unreported indication: Shingles, ANTIBIOTICS (Used to treat Covid) and STEROIDS (Used to treat Covid). Concomitant products included LEVOTHYROXINE, VITAMIN D [VITAMIN D NOS] and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication, ASPIRIN [ACETYLSALICYLIC ACID].    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced MOBILITY DECREASED (Couldn't move my body), PAIN (Body aches), NAUSEA (Nauseous), HEADACHE (Headache) and CHILLS (Chills - literally body shaking). On 19-May-2021, MOBILITY DECREASED (Couldn't move my body), NAUSEA (Nauseous), HEADACHE (Headache) and CHILLS (Chills - literally body shaking) had resolved. At the time of the report, PAIN (Body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient awoke at 11:45 pm and with what was described as a horrible reaction with every symptom. Due to her symptoms, the patient was afraid to get up and potentially pass out. At 2 AM, the patient called her daughter to come over because she was even unable to get up to get water. The symptoms lasted about 16-18 hours and by the next afternoon, she was feeling better. The patient reported that she still had some nausea and achiness at the time of reporting.  Treatment information was not provided by the reporter. Patient took shingles vaccine 2 months before the Moderna Covid vaccine
Difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TREPROSTINIL SODIUM (REMODULIN) injection for Pulmonary arterial hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included SILDENAFIL CITRATE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TREPROSTINIL SODIUM (REMODULIN) (Intravenous) 1.0 mg/ml. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing). At the time of the report, DYSPNOEA (Difficulty breathing) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Initial information for this case was received from healthcare professional on 06 FEBRUARY 2014. A 30-year-old female patient whose past medical history and concomitant medication was not reported became pregnant on an unknown date and had received first dose of an intramuscular ADACEL, batch number C4426AA, dose and site of administration not reported) on 27 DECEMBER 2013 and second dose of an intramuscular ADACEL (batch number: C4426AA, dose and anatomical site of administration not reported) on 10 JANUARY 2014, during pregnancy. The last date of menstrual period was unknown. The estimated date of delivery was 24 MARCH 2014. The patient did not experience any adverse or serious adverse event during pregnancy. She was healthy at the time of this report.